Ohashi T, Yamada N, Terazawa K, Shibata H, et al. Predictive value of immune-modified Glasgow prognostic score in patients with head and neck squamous cell carcinoma treated with nivolumab. J Laryngol Otol 2025 Jul 14:1-25. doi: 10.1017/S0022215125102612.
PMID: 40654056